Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Attention-deficit hyperactivity disorder (ADHD) has a prevalence rate of 7%-9% in the general population of children. However, in children with epilepsy, ADHD has been found to be present in 20%-50% of patients. This paper provides a review of ADHD prevalence in pediatric epilepsy populations and reviews data on specific symptom presentation and attention deficits in patients with epilepsy. This paper also reviews evidence-based treatments for ADHD and specifically the treatment of ADHD as a comorbid condition in children with epilepsy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Willcutt, E. G., Doyle, A. E., Nigg, J. T., Faraone, S. V., & Pennington, B. F. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.006 · Cited by 3,568
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
Subcommittee on Attention-Deficit/Hyperactivity Disorder, S. C. O. Q. I. A. M. (2011) · Pediatrics · doi:10.1542/peds.2011-2654 · Cited by 2,185
Polanczyk, G. V., Willcutt, E. G., Salum, G. A., Kieling, C., & Rohde, L. A. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyt261 · Cited by 1,822
Pliszka, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318054e724 · Cited by 1,765
Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis
Simon, V., Czobor, P., Bálint, S., Mészáros, Á., & Bitter, I. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.048827 · Cited by 1,601
Bush, G., Valera, E. M., & Seidman, L. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.034 · Cited by 714 · cited 1×
“9,10 However, it is likely that more wide-spread neurological abnormalities are involved in ADHD.”
Structural Brain Imaging of Attention-Deficit/Hyperactivity Disorder
Seidman, L. J., Valera, E. M., & Makris, N. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.019 · Cited by 676 · cited 3×
“Abnormalities in frontostriatal circuits have frequently been implicated in ADHD, and imaging studies have supported the presence of abnormalities in these circuits in persons with ADHD.(9,10) However, it is likely that more widespread neurological abnormalities are involved in ADHD.”
InfluentialKuczenski, R., & Segal, D. S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052032.x · Cited by 623 · cited 1×
“Both MPH and AMP work through blockade of dopamine and noradrenaline reuptake into the neurons.(51,52) Furthermore, AMP causes release of catecholamines.”
Michelson, D., Allen, A. J., Busner, J., Casat, C., Dunn, D., Kratochvil, C., Newcorn, J., Sallee, F. R., Sangal, R. B., Saylor, K., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1896 · Cited by 599 · cited 1×
“In a study by Michelson et al, 57 the effect size of atomoxetine in ADHD was determined to be 0.7 with the greatest effects starting at 6 weeks of treatment.”
InfluentialSelf-citationA population survey of mental health problems in children with epilepsy
Davies, S., Heyman, I., & Goodman, R. (2003) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2003.tb00398.x · Cited by 524 · cited 1×
“to be at higher risk for ADHD compared to those with uncomplicated epilepsy.(40) Seizure frequency is positively associated with a diagnosis of ADHD,(41) and symptoms”
Nigg, J. T. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.011 · Cited by 513 · cited 13×
“The samples are too small to comment on the effect of cognitive function or seizure type on the efficacy of medication for ADHD.”
InfluentialPLISZKA, S. R., CRISMON, M. L., HUGHES, C. W., CORNERS, C. K., EMSLIE, G. J., JENSEN, P. S., McCRACKEN, J. T., SWANSON, J. M., & LOPEZ, M. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000215326.51175.eb · Cited by 442
Newcorn, J. H., Kratochvil, C. J., Allen, A. J., Casat, C. D., Ruff, D. D., Moore, R. J., Michelson, D., & Atomoxetine/Methylphenidate Comparative Study Group (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.05091676 · Cited by 336 · cited 1×
“In another large study, using the ADHD Rating Scale IV (ADHD-RS-IV), 45% of patients treated with atomoxetine demonstrated a 40% decrease in core ADHD symptoms.(59) In addition, in children with ADHD with comorbid anxiety, atomoxetine has been shown to be effective in treating the symptoms of both ADHD and anxiety(48,…”
Kessler, R. C., Green, J. G., Adler, L. A., Barkley, R. A., Chatterji, S., Faraone, S. V., Finkelman, M., Greenhill, L. L., Gruber, M. J., Jewell, M., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.146 · Cited by 317
Safety and tolerability of methylphenidate in preschool children with ADHD
WIGAL, T., GREENHILL, L., CHUANG, S., McGOUGH, J., VITIELLO, B., SKROBALA, A., SWANSON, J., WIGAL, S., ABIKOFF, H., KOLLINS, S., et al. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000235082.63156.27 · Cited by 242 · cited 1×
“However, short-acting stimulants and lower doses are often used in children at the age of 5 years or younger due to higher rates of emotional adverse events and slower metabolism of MPH in this age range.(48,55,56) Parent, teacher, and child ADHD scales can be used to follow effectiveness of the medication formulation…”
Pharmacogenetics of Methylphenidate Response in Preschoolers With ADHD
McGOUGH, J., McCRACKEN, J., SWANSON, J., RIDDLE, M., KOLLINS, S., GREENHILL, L., ABIKOFF, H., DAVIES, M., CHUANG, S., WIGAL, T., et al. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000235083.40285.08 · Cited by 126 · cited 1×
“However, short-acting stimulants and lower doses are often used in children at the age of 5 years or younger due to higher rates of emotional adverse events and slower metabolism of MPH in this age range.(48,55,56) Parent, teacher, and child ADHD scales can be used to follow effectiveness of the medication formulation…”
Hernan, A. E., Alexander, A., Jenks, K. R., Barry, J., Lenck-Santini, P.-P., Isaeva, E., Holmes, G. L., & Scott, R. C. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.11.012 · Cited by 73 · cited 1×
“Another study found that frequent interictal spikes in rats were associated with significant inattentiveness.(39) Imaging studies have suggested that CWE and ADHD have disruptions in gray and white matter in a frontostriatal-cerebellar distribution, suggesting N eu ro ps yc hi at ric D is ea se a nd T re at m en t d o…”
Findling, R. L., McBurnett, K., White, C., & Youcha, S. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0103 · Cited by 32 · cited 1×
“63 Alternative nonstimulant medications for the child with ADHD and no evidence of epilepsy include the tricyclic antidepressants and bupropion.”
Cited by
ADHD: Current Concepts and Treatments in Children and Adolescents
Drechsler, R., Brem, S., Brandeis, D., Grünblatt, E., Berger, G., & Walitza, S. (2020) · Neuropediatrics · doi:10.1055/s-0040-1701658 · Cited by 415
Coghill, D., Banaschewski, T., Cortese, S., Asherson, P., Brandeis, D., Buitelaar, J., Daley, D., Danckaerts, M., Dittmann, R. W., Doepfner, M., et al. (2023) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-021-01871-x · Cited by 180
Michaelis, R., Tang, V., Goldstein, L. H., Reuber, M., LaFrance, W. C., Lundgren, T., Modi, A. C., & Wagner, J. L. (2018) · Epilepsia · doi:10.1111/epi.14444 · Cited by 167
Christian, C. A., Reddy, D. S., Maguire, J., & Forcelli, P. A. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.017392 · Cited by 105
“Both boys and girls with epilepsy exhibit higher rates of autism, intellectual disability, and attention-deficit/hyperactivity disorder compared with children in the general population (Socanski et al., 2013; Aaberg et al., 2016; Williams et al., 2016).”
BackgroundBrikell, I., Ghirardi, L., D’Onofrio, B. M., Dunn, D. W., Almqvist, C., Dalsgaard, S., Kuja-Halkola, R., & Larsson, H. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.08.006 · Cited by 85
Self-citation
Metadata
- Authors
- Dunn, D., Williams, A., Giust, J., & Kronenberger, W.
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2016-02
- Volume
- 12
- Pages
- 287
- ISSN
- 1176-6328 (ISSN-L)
- 1178-2021
- OpenAlex
- W2259562551
- Cited by
- 108
- References
- 19
- FWCI
- 11.12
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.